Dr. Jeffrey Cohen said, "Studies suggest that clinical levels of anxiety increased in China after the COVID-19 outbreak and we can expect clinical levels of anxiety to rise in the U.S."
The results "indicate that KarXT, if approved, could represent a game-changing therapeutic advance in the treatment of patients with schizophrenia,” noted Dr. Jeffrey Lieberman.
“For some people, this illness is highly disabling, but there’s a significant number of people who have this illness who are able to live very fulfilling lives,” said Dr. Lisa Dixon.
"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
Researchers at Columbia University used magnetic resonance imaging (MRI) to understand brain structural alterations in children and adolescents with OCD that predict psychotherapy treatment response.